Profile
Arnold Vroege worked as a Director of Quality Assurance at Amsterdam Molecular Therapeutics (AMT) Holding NV from 2007 to 2013.
Prior to that, he was the Head of QA/QC at Solvay Pharmaceuticals SA from 2003 to 2010.
He also worked as the Head of QA Department at Stichting Volksgezondheid en Milieu from 2000 to 2003.
Mr. Vroege obtained an undergraduate degree from the University of Groningen.
Former positions of Arnold Vroege
| Companies | Position | End |
|---|---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
 Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Corporate Officer/Principal | 2013-03-10 |
| Stichting Volksgezondheid en Milieu | Corporate Officer/Principal | - |
Solvay Pharmaceuticals SA
 Solvay Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals SA develops, manufactures, and supplies pharmaceutical products. The company's products include cardio-metabolics, influenza vaccines, adjuvants, and women's and men's healthcare products. It offers fenofibrate, a cardio-metabolic product for treating raised blood lipids and dyslipidemia products that control cholesterol and triglycerides. The firm is headquartered in Brussels, France. | Corporate Officer/Principal | - |
Training of Arnold Vroege
| University of Groningen | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Commercial Services |
Solvay Pharmaceuticals SA
Solvay Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals SA develops, manufactures, and supplies pharmaceutical products. The company's products include cardio-metabolics, influenza vaccines, adjuvants, and women's and men's healthcare products. It offers fenofibrate, a cardio-metabolic product for treating raised blood lipids and dyslipidemia products that control cholesterol and triglycerides. The firm is headquartered in Brussels, France. | Health Technology |
| Stichting Volksgezondheid en Milieu | Miscellaneous |
- Stock Market
- Insiders
- Arnold Vroege
